Type 2 Diabetes Drug
Sitagliptin-Metformin Combo, Synergistically Works Against Type 2 Diabetes
Metformin – commercially available as Glucophage – is a popular diabetes drug that works by making the body more responsive to insulin. On the other hand, Sitagliptin or the Merck diabetes drug Januvia works to boost the body’s ability to lower elevated blood sugar levels.
When combined together in people with type 2 diabetes, sitagliptin and metformin improves blood sugar control in a synergistic fashion, according to a new study by Merck Research Laboratories.
“This was significantly better than results with a single drug and “demonstrated an additive response.”
There was a low incidence of hypoglycemia, or low blood sugar, which was not significantly different from that in the placebo group.
This study shows that the combination of sitagliptin and metformin provides “substantial and additive” improvement in blood sugar levels and is “generally well tolerated.”
Many people can control type 2 diabetes with diet and exercise. Following your specified diet and exercising regularly are crucial factors in keeping your blood sugar regulated.
If you are not able to accomplish this through diet and exercise alone, it is important to balance the amount of metformin and sitagliptin combination against your current diet and exercise regimen. It is important to test your blood sugar and consult with your doctor in order to make sure you have the most effective results from this combination of drugs.
Make sure to be aware of any potential side effects or drug interactions when taking these two drugs in conjuction. Always consult with your physician before taking or discontinuing use of these medications